U.S Physical Therapy EPS - Earnings per Share 2010-2023 | USPH

U.S Physical Therapy eps - earnings per share from 2010 to 2023. Eps - earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.
U.S Physical Therapy Annual EPS
2023 $1.28
2022 $2.25
2021 $2.41
2020 $2.48
2019 $2.45
2018 $1.31
2017 $1.76
2016 $1.64
2015 $1.66
2014 $1.57
2013 $1.05
2012 $1.51
2011 $1.75
2010 $1.32
2009 $1.00
U.S Physical Therapy Quarterly EPS
2023-12-31 $-0.45
2023-09-30 $0.51
2023-06-30 $0.64
2023-03-31 $0.58
2022-12-31 $-0.01
2022-09-30 $0.72
2022-06-30 $0.87
2022-03-31 $0.67
2021-12-31 $0.72
2021-09-30 $0.66
2021-06-30 $0.82
2021-03-31 $0.21
2020-12-31 $0.68
2020-09-30 $0.61
2020-06-30 $0.99
2020-03-31 $0.20
2019-12-31 $0.55
2019-09-30 $0.66
2019-06-30 $0.85
2019-03-31 $0.39
2018-12-31 $0.43
2018-09-30 $0.13
2018-06-30 $0.48
2018-03-31 $0.27
2017-12-31 $0.58
2017-09-30 $0.41
2017-06-30 $0.39
2017-03-31 $0.38
2016-12-31 $0.42
2016-09-30 $0.38
2016-06-30 $0.48
2016-03-31 $0.36
2015-12-31 $0.37
2015-09-30 $0.47
2015-06-30 $0.48
2015-03-31 $0.34
2014-12-31 $0.35
2014-09-30 $0.43
2014-06-30 $0.52
2014-03-31 $0.27
2013-12-31 $0.31
2013-09-30 $0.02
2013-06-30 $0.41
2013-03-31 $0.31
2012-12-31 $0.34
2012-09-30 $0.38
2012-06-30 $0.41
2012-03-31 $0.38
2011-12-31 $0.69
2011-09-30 $0.34
2011-06-30 $0.41
2011-03-31 $0.31
2010-12-31 $0.34
2010-09-30 $0.33
2010-06-30 $0.38
2010-03-31 $0.27
2009-12-31 $0.20
2009-09-30 $0.26
2009-06-30 $0.31
2009-03-31 $0.23
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $1.516B $0.605B
U.S. Physical Therapy, Inc. is the largest publicly-traded, pure-play operator of outpatient physical and occupational therapy clinics. The clinics provide pre- and post-operative care for a variety of orthopedic-related disorders and sports-related injuries, rehabilitation of injured workers and preventative care. USPh also manages several physical therapy facilities for third parties, including physician groups. Each of USPh's clinics are directed by a licensed physical therapist that drive patient volume via local physicians, former patients and other referral sources. Marketing representatives are used to further augment sales. Historically, USPh has grown its business through de novo development; approximately two-thirds of USPh clinics were originally start-ups. Strategic acquisitions, which accelerate the Company's growth, are structured like the de novo partnerships, with significant ownership retained by founders.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $16.392B 9.92
Quest Diagnostics (DGX) United States $14.915B 15.41
DaVita (DVA) United States $11.709B 15.93
Chemed (CHE) United States $8.472B 26.30
Encompass Health (EHC) United States $8.259B 21.25
Elanco Animal Health (ELAN) United States $6.552B 14.90
Option Care Health (OPCH) United States $5.147B 19.48
RadNet (RDNT) United States $3.314B 96.80
Amedisys (AMED) United States $2.999B 21.25
LifeStance Health (LFST) United States $2.370B 0.00
Astrana Health (ASTH) United States $2.057B 25.68
Addus HomeCare (ADUS) United States $1.548B 23.52
Pennant (PNTG) United States $0.624B 36.46
Aveanna Healthcare Holdings (AVAH) United States $0.423B 0.00
Atai Life Sciences (ATAI) Germany $0.323B 0.00
Daxor (DXR) United States $0.046B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.029B 0.00
ATI Physical Therapy (ATIP) United States $0.018B 0.00
Psychemedics (PMD) United States $0.015B 0.00
Ontrak (OTRK) United States $0.014B 0.00
Novo Integrated Sciences (NVOS) United States $0.010B 0.00
IMAC Holdings (BACK) United States $0.005B 0.00